#
Ferric carboxymaltose Intravenous
  • Treatments
  • Iron Deficiency Anemia
  • Ferric carboxymaltose (Intravenous)

Ferric carboxymaltose (Intravenous)

Medically reviewed by Drugs.com. Last updated on Apr 11, 2022.

Commonly used brand name(s)

In the U.S.

  • Injectafer

Available Dosage Forms:

  • Solution

Uses for ferric carboxymaltose

Ferric carboxymaltose injection is an iron replacement product that is used to treat iron deficiency anemia (not enough iron in the blood) in patients with non-dialysis dependent chronic kidney disease (CKD), and in patients who cannot take iron supplements or who are taking iron supplements that did not work well.

Iron is a mineral that the body needs to produce red blood cells. When the body does not get enough iron, it cannot produce the number of normal red blood cells needed to keep you in good health. This condition is called iron deficiency (iron shortage) or iron deficiency anemia.

Ferric carboxymaltose is to be given only by or under the direct supervision of a doctor.

Before using ferric carboxymaltose

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For ferric carboxymaltose, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to ferric carboxymaltose or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of ferric carboxymaltose injection in children younger than 1 year of age. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ferric carboxymaltose injection in the elderly. However, elderly patients are more sensitive to the effects of ferric carboxymaltose than younger adults.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving ferric carboxymaltose, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using ferric carboxymaltose with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

  • Baloxavir Marboxil
  • Bictegravir
  • Dimercaprol
  • Eltrombopag
  • Erdafitinib
  • Magnesium Sulfate
  • Raltegravir

Using ferric carboxymaltose with any of the following medi...